Related Experiment Video
Updated: May 28, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Race against clots: the challenges of managing antithrombin deficiency in the ICU
Andres Giglio Jimenez1,2, Paola Aravena2,3, Valentina Ibañez4
1Critical Care Department, Finis Terrae University Faculty of Medicine, Santiago, Metropolitana, Chile aegiglio@uc.cl.
We present the case of a man in his 50s with a history of recurrent unprovoked venous thromboembolism who developed haemorrhagic shock due to venous intestinal ischaemia. Despite anticoagulation and monitoring of anti-Xa levels, the thrombosis progressed, leading to complete necrosis and perforation of the small bowel wall, persistent septic shock and ultimately death. The clinical course and family history raised suspicion for hereditary antithrombin deficiency, a rare but potentially catastrophic thrombophilia. This case highlights the importance of considering inherited thrombophilia in critically ill patients with progressive thrombosis despite adequate anticoagulation, and the challenges of managing these conditions in the intensive care unit.
We present the case of a man in his 50s with a history of recurrent unprovoked venous thromboembolism who developed haemorrhagic shock due to venous intestinal ischaemia. Despite anticoagulation and monitoring of anti-Xa levels, the thrombosis progressed, leading to complete necrosis and perforation of the small bowel wall, persistent septic shock and ultimately death. The clinical course and family history raised suspicion for hereditary antithrombin deficiency, a rare but potentially catastrophic thrombophilia. This case highlights the importance of considering inherited thrombophilia in critically ill patients with progressive thrombosis despite adequate anticoagulation, and the challenges of managing these conditions in the intensive care unit.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Clot Retraction and Fibrinolysis
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:

